Replies to post #1275 on Ariad Pharmaceuticals Inc fka ARIA

[DonShimoda]

Heck, they haven't even finished or given any data in P2 trials yet, and it doesn't look like its coming any time soon.

And you reached the conclusion that more data isn't forthcoming based on what? It's rather weak reasoning to assume the negative proves the positive.

[ampakine]

You must have evidence of a quote from one of the "best minds" in the sarcoma community that says ridaforolimus is essentially a shoe-in at 95% success rate

You misunderstand!!! No responsible oncologist would say anything of the sort. What I meant (obviously) is that in designing the trials, Ariad and Sarcoma specialists ("thought leaders" in Dr.Berger's words) had a vast array of data, years of clinical feedback to utilize, in order to select a patient population and a trial protocol that was likely to result in a successful outcome. SUCCEED is not a shot in the dark! The unnamed "analysts" you cite, are clearly disadvantaged by lack of relevant data, and a substantial lack of seriousness in their prognostications.